{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T08:23:23Z","timestamp":1781857403535,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,8,17]],"date-time":"2016-08-17T00:00:00Z","timestamp":1471392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s10157-016-1321-5","type":"journal-article","created":{"date-parts":[[2016,8,17]],"date-time":"2016-08-17T11:02:37Z","timestamp":1471431757000},"page":"705-713","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Results of a multicenter prospective clinical study in Japan for evaluating efficacy and safety of desensitization protocol based on rituximab in ABO-incompatible kidney transplantation"],"prefix":"10.1007","volume":"21","author":[{"name":"The IDEC-C2B8 ABO-I KTx Study Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhide","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Takahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Fuchinoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yagisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Aikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Watarai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunari","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunio","family":"Morozumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohide","family":"Shimazu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,17]]},"reference":[{"key":"1321_CR1","first-page":"1078","volume":"23","author":"K Takahashi","year":"1991","unstructured":"Takahashi K, Tanabe K, Ooba S, et al. Prophylactic use of a new immunosuppressive agent, deoxyspergualin, in patients with kidney transplantation from ABO-incompatible or preformed antibody-positive donors. Transplant Proc. 1991;23:1078.","journal-title":"Transplant Proc"},{"key":"1321_CR2","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1600-6143.2004.00464.x","volume":"4","author":"K Takahashi","year":"2004","unstructured":"Takahashi K, Saito K, Takahara S, et al. The Japanese ABO-incompatible kidney transplantation committee. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant. 2004;4:1089.","journal-title":"Am J Transplant"},{"key":"1321_CR3","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1399-3089.2006.00278.x","volume":"13","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Saito K. Present status of ABO-incompatible kidney transplantation in Japan. Xenotransplantation. 2006;13:118.","journal-title":"Xenotransplantation"},{"key":"1321_CR4","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ncpneph0967","volume":"4","author":"N Ichimaru","year":"2008","unstructured":"Ichimaru N, Takahara S. Japan\u2019s experience with living-donor kidney transplantation across ABO barriers. Nat Clin Pract Nephrol. 2008;4:682.","journal-title":"Nat Clin Pract Nephrol"},{"issue":"Suppl 1","key":"1321_CR5","first-page":"18","volume":"13","author":"A Aikawa","year":"2015","unstructured":"Aikawa A, Saito K, Takahashi K. Trends in ABO-incompatible kidney transplantation. Exp Clin Transplant. 2015;13(Suppl 1):18.","journal-title":"Exp Clin Transplant"},{"key":"1321_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trre.2012.07.003","volume":"27","author":"K Takahashi","year":"2013","unstructured":"Takahashi K, Saito K. ABO-incompatible kidney transplantation. Transplant Rev. 2013;27:1.","journal-title":"Transplant Rev"},{"key":"1321_CR7","volume-title":"ABO-incompatible kidney transplantation","author":"K Takahashi","year":"2001","unstructured":"Takahashi K. ABO-incompatible kidney transplantation. Amsterdam: Elsevier; 2001."},{"key":"1321_CR8","volume-title":"Accommodation in ABO-incompatible kidney transplantation","author":"K Takahashi","year":"2004","unstructured":"Takahashi K. Accommodation in ABO-incompatible kidney transplantation. Amsterdam: Elsevier; 2004."},{"key":"1321_CR9","volume-title":"ABO-incompatible kidney transplantation\u2014establishing a scientific framework","author":"K Takahashi","year":"2007","unstructured":"Takahashi K. ABO-incompatible kidney transplantation\u2014establishing a scientific framework. Amsterdam: Elsevier; 2007."},{"key":"1321_CR10","volume-title":"ABO-incompatible kidney transplantation\u2014why is hyperacute rejection absent?","author":"K Takahashi","year":"2011","unstructured":"Takahashi K. ABO-incompatible kidney transplantation\u2014why is hyperacute rejection absent?. Amsterdam: Elsevier; 2011."},{"key":"1321_CR11","volume-title":"ABO-incompatible kidney transplantation\u2014overcoming hyperacute rejection and establishing clinical strategies","author":"K Takahashi","year":"2013","unstructured":"Takahashi K. ABO-incompatible kidney transplantation\u2014overcoming hyperacute rejection and establishing clinical strategies. Amsterdam: Elsevier; 2013."},{"key":"1321_CR12","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/01.TP.0000078622.43689.D4","volume":"76","author":"G Tyd\u00e9n","year":"2003","unstructured":"Tyd\u00e9n G, Kumlien G, Fehrman I. Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab. Transplantation. 2003;76:730.","journal-title":"Transplantation"},{"key":"1321_CR13","first-page":"231","volume":"28","author":"GPJ Alexandre","year":"1985","unstructured":"Alexandre GPJ, Bruyere MDE, Squifflet JP, Moriau M, Latinne D, Pirson Y. Human ABO-incompatible living donor renal homografts. Neth J Med. 1985;28:231.","journal-title":"Neth J Med"},{"key":"1321_CR14","first-page":"452","volume":"18","author":"GPJ Alexandre","year":"1986","unstructured":"Alexandre GPJ, Squifflet JP, Bruy\u00e8re MDE, et al. ABO-incompatible related and unrelated living donor renal allografts. Transplant Proc. 1986;18:452.","journal-title":"Transplant Proc"},{"key":"1321_CR15","first-page":"4538","volume":"19","author":"GPJ Alexandre","year":"1987","unstructured":"Alexandre GPJ, Squifflet JP, Bruy\u00e8re MDE, et al. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc. 1987;19:4538.","journal-title":"Transplant Proc"},{"key":"1321_CR16","first-page":"583","volume":"5","author":"GPJ Alexandre","year":"1991","unstructured":"Alexandre GPJ, Latinne D, Gianello P, Squifflet JP. Preformed cytotoxic antibodies and ABO-incompatible grafts. Clin Transplant. 1991;5:583.","journal-title":"Clin Transplant"},{"key":"1321_CR17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s10157-007-0461-z","volume":"11","author":"K Takahashi","year":"2007","unstructured":"Takahashi K. Recent findings in ABO-incompatible kidney transplantation: classification and therapeutic strategy for acute antibody-mediated rejection due to ABO-blood-group-related antigens during the critical period preceding the establishment of accommodation. Clin Exp Nephrol. 2007;11:128.","journal-title":"Clin Exp Nephrol"},{"key":"1321_CR18","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1399-3089.2006.00296.x","volume":"13","author":"T Kobayashi","year":"2006","unstructured":"Kobayashi T, Saito K. A series of surveys on assay for anti-A\/B antibody by Japanese ABO-Incompatible Transplantation Committee. Xenotransplantation. 2006;13:136.","journal-title":"Xenotransplantation"},{"key":"1321_CR19","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1097\/TP.0b013e3181dc0999","volume":"89","author":"T Takagi","year":"2010","unstructured":"Takagi T, Ishida H, Shirakawa H, Shimizu T, Tanabe K. Evaluation of low-dose rituximab induction therapy in living related kidney transplantation. Transplantation. 2010;89:1466.","journal-title":"Transplantation"},{"key":"1321_CR20","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/TP.0b013e31820f08e8","volume":"91","author":"S Fuchinoue","year":"2011","unstructured":"Fuchinoue S, Ishii Y, Sawada T, et al. The 5-year outcome of ABO-incompatible kidney transplantation with rituximab induction. Transplantation. 2011;91:853.","journal-title":"Transplantation"},{"key":"1321_CR21","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1399-0012.2010.01384.x","volume":"25","author":"H Shirakawa","year":"2011","unstructured":"Shirakawa H, Ishida H, Shimizu T, et al. The low dose of rituximab in ABO-incompatible kidney transplantation without a splenectomy: a single-center experience. Clin Transplant. 2011;25:878.","journal-title":"Clin Transplant"},{"key":"1321_CR22","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1600-6143.2011.03830.x","volume":"12","author":"N Kohei","year":"2012","unstructured":"Kohei N, Hirai T, Omoto K, Ishida H, Tanabe K. Chronic antibody-mediated rejection is reduced by targeting B-Cell immunity during an introductory period. Am J Transplant. 2012;12:469.","journal-title":"Am J Transplant"},{"key":"1321_CR23","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/00007890-200211150-00001","volume":"74","author":"T Sawada","year":"2002","unstructured":"Sawada T, Fuchinoue S, Teraoka S. Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis. Transplantation. 2002;74:1207.","journal-title":"Transplantation"},{"key":"1321_CR24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.trim.2014.06.001","volume":"31","author":"K Kabei","year":"2014","unstructured":"Kabei K, Uchida J, Iwai T, et al. Late-onset neutropenia and acute rejection in ABO-incompatible kidney transplant recipients receiving rituximab and mycophenolate mofetil. Transpl Immunol. 2014;31:92.","journal-title":"Transpl Immunol"},{"key":"1321_CR25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1399-3089.2006.00277.x","volume":"13","author":"K Saito","year":"2006","unstructured":"Saito K, Nakagawa Y, Suwa M, et al. Pinpoint targeted immunosuppression: anti-CD20\/MMF desensitization with anti-CD25 in successful ABO-incompatible kidney transplantation without splenectomy. Xenotransplantation. 2006;13:111.","journal-title":"Xenotransplantation"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-016-1321-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-016-1321-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-016-1321-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-016-1321-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T11:53:31Z","timestamp":1512647611000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-016-1321-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,17]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["1321"],"URL":"https:\/\/doi.org\/10.1007\/s10157-016-1321-5","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,17]]}}}